NCT00409643View on ClinicalTrials.gov

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

1,259

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Hypertension
Interventions
DRUG

valsartan+amlodipine combination

DRUG

valsartan

DRUG

amlodipine

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Sites in Germany, Germany

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY